A systematic review and meta-analysis of randomised clinical trials (RCTs) underscores the superior efficacy of bariatric and metabolic...

A study from the Keck School of Medicine of USC found that sucralose, a common sugar substitute, alters brain activity related to hunger...

Rani Therapeutics has announced pharmacokinetic and pharmacodynamic data from a preclinical study evaluating RT-114, a GLP-1/GLP-2 dual...

A study by scientists at the University of California, Berkeley, suggests that pleasure in eating, even eating junk food, is key to...

A large majority of older Americans feel that health insurance - including Medicare - should cover anti-obesity medications, according to...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Palatin Technologies has announced the FDA has granted "orphan drug" designation to PL7737, an oral treatment that activates the...

Researchers from the University of Cambridge have developed a smartphone app that uses machine learning to accurately determine body...

The United Laboratories International Holdings Limited’s (TUL) wholly-owned subsidiary The United Bio-Technology (Hengqin) Co., Ltd....

Massachusetts Institute of Technology (MIT) researchers have revealed a drug delivery system that "paints" glucagon-like peptide-1...

The Obesity Action Coalition (OAC) and The Obesity Society (TOS) have sent a letter to the FDA, along with more than 20 leading...

Allurion Technologies has announced initial results on the combination of the Allurion Program with low-dose GLP-1 therapy to optimise...